AI Verdict
ROG has stronger fundamentals based on our AI analysis.
ROG vs RNTX Fundamental Comparison
| Metric | ROG | RNTX |
|---|---|---|
| Revenue | $810.8M | $0.0 |
| Net Income | $-61.8M | $-49.9M |
| Net Margin | -7.6% | N/A |
| ROE | -5.2% | -294.8% |
| ROA | -4.3% | -206.4% |
| Current Ratio | 3.97x | 0.70x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $-3.40 | $-1.96 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ROG vs RNTX: Frequently Asked Questions
Is ROG or RNTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), ROG has stronger fundamentals. ROG is rated HOLD (35% confidence) while RNTX is rated STRONG SELL (95% confidence). This is not investment advice.
How does ROG compare to RNTX fundamentally?
ROGERS CORP has ROE of -5.2% vs Rein Therapeutics, Inc.'s -294.8%. Net margins are -7.6% vs N/A respectively.
Which stock pays higher dividends, ROG or RNTX?
ROG has a dividend yield of N/A or no dividend while RNTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ROG or RNTX for long term?
For long-term investing, consider that ROG has HOLD rating with 35% confidence, while RNTX has STRONG SELL rating with 95% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ROG vs RNTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ROG vs RNTX, the AI consensus favors ROG based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.